Location History:
- Niigata, JP (2019 - 2020)
- Chuo-ku, JP (2023)
Company Filing History:
4 out of 811 
4 out of 260 
Years Active: 2019-2025
Title: Masaru Imamura: Innovator in Cancer Treatment
Introduction
Masaru Imamura is a prominent inventor based in Niigata, Japan. He has made significant contributions to the field of immunology, particularly in the development of natural killer (NK) cell therapies for cancer treatment. With a total of four patents to his name, Imamura's work is at the forefront of innovative cancer therapies.
Latest Patents
Imamura's latest patents include groundbreaking inventions related to natural killer cells expressing membrane-bound interleukin 15 (mbIL15). One of his notable patents provides methods for producing NK cells that express all or a functional portion of interleukin-15 (IL-15). This invention also outlines methods for using these NK cells to treat cancer in subjects or to enhance their expansion and survival. Another patent focuses on immune cells expressing mbIL15 and their applications in cancer treatment, further emphasizing the potential of these innovative therapies.
Career Highlights
Throughout his career, Imamura has worked with esteemed institutions such as the National University of Singapore and St. Jude Children's Research Hospital. His research has significantly advanced the understanding and application of NK cell therapies, positioning him as a key figure in the field of cancer immunotherapy.
Collaborations
Imamura has collaborated with notable professionals in the field, including Dario Campana and David Shook. These collaborations have contributed to the development of innovative approaches in cancer treatment, enhancing the impact of his research.
Conclusion
Masaru Imamura's contributions to cancer treatment through his innovative patents and collaborations highlight his role as a leading inventor in the field of immunology. His work continues to pave the way for advancements in cancer therapies, offering hope for improved treatment options.